Plain-English translation of NCT07518784 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing a new device called LiverScope®—a small, portable scanner that uses similar technology to MRI machines to evaluate fatty liver disease. Researchers want to see how well this new device works compared to standard MRI scans and other liver tests. This is the second phase of the study, building on what they learned in the first phase.
Fatty liver disease affects many people, and doctors need better ways to evaluate it that are quick, portable, and accessible in regular doctor's offices. This study aims to see if the new device could eventually offer patients a faster, easier alternative to traditional large MRI machines.
You likely qualify if…
You likely don't qualify if…
You would come in for a single visit lasting about one to two hours. During this visit, you would have a scan with the new LiverScope® device, a standard MRI scan, an optional ultrasound-based liver test (FibroScan), a blood draw, and you would fill out some questionnaires about your health. That's it—no follow-up visits or ongoing treatment required.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Collaborators
Livivos, Inc., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrollment target
~26 participants
Started
April 2026
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yesenia Covarrubias
University of California, San Diego
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.